[1] |
WANG Qian, LI Yong, WANG Yiyi, LIU Hongjie, LI Wei.
Pulsed dye laserombined with calcipotriol betamethasone cream in the treatment of nail psoriasis: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(2): 93-98.
|
[2] |
YOU Zimeng, LIU Hongjie, YANG Lifeng, YAN Wei.
Psoriasis vulgaris with nail change treated with secukinumab: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(8): 558-561.
|
[3] |
CHEN Jie, BAO Jun.
Application of biological agents used in China in special population with psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(3): 199-202.
|
[4] |
ZHAO Liyuan, LIU Liming, YAN Xuewen, JIA Jing.
Secukinumab in the treatment of nail psoriasis: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(11): 823-825.
|
[5] |
MAO Mengmeng, BAI Bingxue.
Update of the biological for treating hidradenitis suppurativa
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(1): 56-59.
|
[6] |
SUN Weina, LI Yuzhen.
Update of treatment for erythrodermic psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(9): 614-617.
|
[7] |
HU Zhonghui, SUN Qing.
Update of biological agents in the treatment of psoriasis comorbidities
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(7): 471-476.
|
[8] |
CHEN Jialin, LIU Guoyan, ZHOU Guizhi, TIAN Hongqing.
Pityriasis rubra pilaris successfully treated with secukinumab: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(12): 783-786.
|
[9] |
SUN Yonghu, ZHANG Furen.
A child with psoriasis successfully treated with interleukin-17A antagonist and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(1): 30-31.
|
[10] |
XIANG Zhi, MA Yiping, CUI Pangen, CHEN Min.
Effect of HLA-Cw6 allele on the efficacy of biological agents for the treatment of psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(6): 321-326.
|
[11] |
LIU Huiying, QI Jing, SONG Cuihao, WANG Rui, HUANG Min, XIE Fang, LI Chengxin.
Efficacy of infliximab in the long-term treatment of psoriasis arthropathica
[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(12): 710-714.
|
[12] |
DAI Huatuo, REN Yunqing.
Update on pharmacogenetics of biological agents in the treatment of psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(11): 696-700.
|
[13] |
GUO Yuan, CAI Yutian , GUO Ningning, , LI Yumei , ..
Immune mechanism and clinical research progress in the treatment of atopic dermatitis with dupilumab
[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(2): 125-128.
|